Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals had revenue of $166.80M in the quarter ending March 31, 2025, a decrease of -3.21%. This brings the company's revenue in the last twelve months to $775.84M, up 48.04% year-over-year. In the year 2024, Apellis Pharmaceuticals had annual revenue of $781.37M with 97.02% growth.

• Revenue (ttm): $775.84M
• Revenue Growth: +48.04%
• P/S Ratio: 2.78
• Revenue / Employee: $1,092,731
• Employees: 710
• Market Cap: 2.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	781.37M	384.78M	97.02%
Dec 31, 2023	396.59M	321.17M	425.83%
Dec 31, 2022	75.42M	8.86M	13.31%
Dec 31, 2021	66.56M	-184.08M	-73.44%
Dec 31, 2020	250.65M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.